Janux Therapeutics, Inc. (JANX)

13.86 +0.16 (+1.13%) USD  |  NASDAQ  |  Feb 26, 15:47
More

Janux Therapeutics Net Change in Capital Expenditures (Quarterly)

Net Change in Capital Expenditures (Quarterly) Chart

View Net Change in Capital Expenditures (Quarterly) for JANX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years

View Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (Quarterly) Benchmarks

View Net Change in Capital Expenditures (Quarterly) Benchmarks
Start Trial
Bristol Myers Squibb Co. Upgrade
Eli Lilly & Co. Upgrade
Ionis Pharmaceuticals, Inc. --
MannKind Corp. Upgrade
EyePoint Plc Upgrade